Capabilities of gravitational surgery for improvement of treatment results in patients with diabetic foot syndrome

Abstract

Aim. Improvement of complex treatment results in patients with diabetic foot syndrome by introducing methods of gravitational surgery and α-lipoic acid.

Methods. The results of treatment were analyzed for 558 patients with diabetic foot syndrome treated in Scientific Centre of Surgery named after M.A. Topchubashov (Baku, Azerbaijan) from 1988 to 2015. The age varied from 28 to 83 years. The patients included 416 men and 142 women. The control group included 90 patients who at the perioperative period underwent basic therapy including antibiotics, anticoagulants, antiaggregants, dextrans, angioprotectors, spasmolytics, corticosteroids, narcotic and non-narcotic analgesics. The study group included 468 patients, along with traditional therapy receiving efferent methods (plasmapheresis, ultraviolet blood irradiation, ozone therapy) and α-lipoic acid. 282 patients of the study group received outpatient treatment and 186 - complex inpatient surgical treatment. A comparative evaluation of the results was performed separately in three groups: angiopathy, neuropathy, angioneuropathy. The results were evaluated by clinical and instrumental examinations before and after treatment (6, 12, 60 months and more).

Results. In the study group a satisfactory result of treatment was registered in 85.5% of patients, in the control group - in 62.2%, unsatisfactory in 14.5 and 37.8% of patients, respectively (p=0.046).

Conclusion. The use of efferent methods and α-lipoic acid provided prompt elimination of numerous pathogenetic disorders observed in diabetes mellitus, decrease of amputation frequency and improvement of complex surgical treatment results in patients with diabetic foot syndrome.

Keywords

diabetes mellitus / endogenous intoxication / plasmapheresis / ultraviolet irradiation / ozone / critical ischemia

References

[1] American Diabetes Association. Report of the Expert Committee. Diabetes Care. 2014; (1): 4–19.

[2] American Diabetes Association. Report of the Expert Committee. Diabetes Care. 2014; (1): 4-19.

[3] Abyshov N.S., Zakirdzhaev E.D., Zeynalova G.M. et al. Diabetic foot syndrome – actual aspects. Surgery. 2016; (3): 96–102. (In Azer.)

[4] Абышов Н.С., Закирджаев Э.Д., Зейналова Г.М. и др. Синдром диабетической стопы - актуальные аспекты. Surgery. 2016; (3): 96-102.

[5] Balabolkin M.I., Kreminskaya V.M., Klebanova E.M. Role of an oxidizing stress in the pathogenesis of diabetic neuropathy and a possibility of its correction by α-Acidum lipoicum of acid. Problemy endokrinologii. 2005; (3): 22–33. (In Russ.)

[6] Балаболкин М.И., Креминская В.М., Клебанова Е.М. Роль окислительного стресса в патогенезе диабетической невропатии и возможность его коррекции препаратами α-липоевой кислоты. Пробл. эндокринол. 2005; (3): 22-33.

[7] Guryeva I.V., Komelyagina E.Y., Kuzina I.V., Ametov A.S. Diabeticheskaya perifericheskaya sensomotornaya neyropatiya. Patogenez, klinika diagnostika. Metodicheskie rekomendatsii. (Diabetic peripheral sensomotor neuropathy. Pathogenesis, clinic diagnostics. Methodical recommendations.) Moscow: Meditsina. 2008: 24 p. (In Russ.)

[8] Гурьева И.В., Комелягина Е.Ю., Кузина И.В., Аметов А.С. Диабетическая периферическая сенсомоторная невропатия. Патогенез, клиника диагностика. Методические рекомендации. М.: Медицина. 2008; 24 с.

[9] Estrada D.E., Volchuk A., Ramlal T. et al. Stimulation of glucose uptake and translocation of glucose transporters in muscle cells by lipoic acid (thioctic acid). Diabetologie und Stoffwechsel. 1996; 5 (3): 41–45.

[10] Estrada D.E., Volchuk A., Ramlal T. et al. Stimulation of glucose uptake and translocation of glucose transporters in muscle cells by lipoic acid (thioctic acid). Diabetologie und Stoffwechsel. 1996; 5 (3): 41-45.

[11] Voinov V.A. Efferentnaya terapiya. Membrannyy plazmaferez. (Efferent therapy. Membrane plasmapheresis.) Moscow: Meditsina. 2002; 270 p. (In Russ.)

[12] Воинов В.А. Эфферентная терапия. Мембранный плазмаферез. М.: Медицина. 2002; 270 с.

[13] Dzheyranov F.D., Garagezova A.R., Akhmedov M.B., Rakhmani S.A. Some methods of detoxification therapy in the complex treatment of critical lower limb ischemia in patients with diabetes mellitus. Azerbaydzhanskiy meditsinskiy zhurnal. 1996; (4): 113–117. (In Russ.)

[14] Джейранов Ф.Д., Гарагезова А.Р., Ахмедов М.Б., Рахмани С.А. Некоторые методы детоксикационной терапии в комплексном лечении критической ишемии нижних конечностей у больных сахарным диабетом. Азербайджанский мед. ж. 1996; (4): 113-117.

[15] Belmin J., Valensi P. Diabetic neuropathy in elderly patients. What can be done? Drugs Aging. 1996; 8 (6): 416–429. DOI: 10.2165/00002512-199608060-00003.

[16] Belmin J., Valensi P. Diabetic neuropathy in elderly patients. What can be done? Drugs Aging. 1996; 8 (6): 416-429. DOI: 10.2165/00002512-199608060-00003.

[17] Karandashov V.I., Petukhov E.B., Zrodnikov B.C. Kvantovaya terapiya. (Quantum Therapy.) Moscow: Meditsina. 2004; 336 p. (In Russ.)

[18] Карандашов В.И., Петухов Е.Б., Зродников B.C. Квантовая терапия. М.: Медицина. 2004; 336 с.

[19] Yuryev M.F., Boyarinov G.A., Dudina E.V. Ozone-oxygen therapy in the acute period of severe craniocerebral trauma. Revista Ozonoterapia. 2009; 1 (3): 196–197. (In Russ.)

[20] Юрьев М.Ф., Бояринов Г.А., Дудина Е.В. Озоно-кислородная терапия в остром периоде тяжёлой черепно-мозговой травмы. Revista Ozonoterapia. 2009; 1 (3): 196-197.

[21] Thompson G.R. LDL apheresis. Atherosclerosis. 2003; 167: 1–3. DOI: 10.1016/s0021-9150(02)00251-4.

[22] Thompson G.R. LDL apheresis. Atherosclerosis. 2003; 167: 1-3. DOI: 10.1016/s0021-9150(02)00251-4.

[23] Kotov S.V., Kalinin A.P., Rudakova I.G. Diabeticheskaya nevropatiya. (Diabetic neuropathy.) Moscow: Meditsina. 2000; 40 p. (In Russ.)

[24] Котов С.В., Калинин А.П., Рудакова И.Г. Диабетическая невропатия. М.: Медицина. 2000; 40 c.

[25] Ziegler D., Ametov A., Barinov A. et al. Oral treatment with alpha-lipoicacid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes care. 2006; 29 (11): 2365–2370. DOI: 10.2337/dc06-1216.

[26] Ziegler D., Ametov A., Barinov A. et al. Oral treatment with alpha-lipoicacid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes care. 2006; 29 (11): 2365-2370. DOI: 10.2337/dc06-1216.

[27] Giugliano D., Ceriello A., Paolisso G. Diabetes mellitus, hypertension and cardiovascular pathology: the role of oxydative stress? Metabolism. 1995; 44: 363–368. DOI: 10.1016/0026-0495(95)90167-1.

[28] Giugliano D., Ceriello A., Paolisso G. Diabetes mellitus, hypertension and cardiovascular pathology: the role of oxydative stress? Metabolism. 1995; 44: 363-368. DOI: 10.1016/0026-0495(95)90167-1.

[29] Dedov I.I. Diabetes mellitus is a problem of the 21st century. Vrach. 2000; (1): 4–5. (In Russ.)

[30] Дедов И.И. Сахарный диабет - проблема ХХI века. Врач. 2000; (1): 4-5.

[31] Guseynov B.A., Akhmedov M.B. Ekstrakorporalnoe ultrafioletovoe obluchenie krovi v prakticheskoy meditsine. (Extracorporeal ultraviolet irradiation of blood in practical medicine.) Baku: Meditsina. 2000; 202 p. (In Russ.)

[32] Гусейнов Б.А., Ахмедов М.Б. Экстракорпоральное ультрафиолетовое облучение крови в практической медицине. Баку: Медицина. 2000; 202 c.

[33] Dibirov M.D., Gadzhimuradov R.U., Dibirov A.A. et al. The results of reconstructive surgery for diabetic foot syndrome in gerontological patients. Angiologiya i sosudistaya khirurgiya. 2011; 17 (1): 145–149. (In Russ.)

[34] Дибиров М.Д., Гаджимурадов Р.У., Дибиров А.А. и др. Результаты реконструктивных операций при синдроме диабетической стопы у геронтологических больных. Ангиол. и сосудист. хир. 2011; 17 (1): 145-149.

RIGHTS & PERMISSIONS

Akhmedov M.B., Abushov N.S., Zakirdzaev E.D., Kosaev D.V., Babaev N.I., Kuliev R.A., Tagizade G.T.